- Researchers are developing lab-grown blood platelets using silk fibroin to address chronic supply shortages.
- Current platelet products have a very short shelf life of five days and require room-temperature storage, making them vulnerable to donation fluctuations.
- The project, funded by the EU, uses an artificial bone marrow bioreactor to mimic the environment where platelets are naturally produced.
The Platelet Challenge
- Platelets are essential for cancer chemotherapy, surgery, and emergency medicine.
- Global supply relies on donors, but approximately 15% of transfusions require specific tissue matches, complicating logistics.
- Supplies are prone to disruptions during summer months or pandemics due to the limited five-day shelf life.
Recreating Bone Marrow
- Platelets are naturally produced by megakaryocytes in the bone marrow.
- Researchers from the SilkFUSION and SilkPlatelet initiatives utilized silk fibroin—a protein from silkworms—because it is biocompatible, flexible, and strong.
- This material allows for the creation of a 'niche' that mimics the human bone marrow environment, supporting reliable cell development.
Future Outlook and Applications
- Efficiency is being improved through genetically modified stem cells to optimize production costs.
- The SILKink project developed a 3D-printable silk 'bio-ink' to create accurate tissue models for drug testing and blood disease research.
- While clinical use is years away, researchers have successfully conducted small animal trials and are moving toward scaling the technology for human transfusion needs.
This summary was generated by AI from the original article and may omit nuance or later updates. How everytldr works